We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
+7.07%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+594.2%
AUM
$7.86B
AUM Growth
-$1.18B
Cap. Flow
-$1.51B
Cap. Flow %
-19.2%
Top 10 Hldgs %
19.15%
Holding
3,648
New
1,015
Increased
681
Reduced
769
Closed
1,159

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$132M
2
AAPL icon
Apple
AAPL
+$82.1M
3
BP icon
BP
BP
+$66M
4
DEO icon
Diageo
DEO
+$54.2M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$49.9M

Sector Composition

Rank Sector Weight
1 Energy 4.3%
2 Technology 4.3%
3 Communication Services 4.24%
4 Healthcare 4.07%
5 Consumer Discretionary 2.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAGS
2226
DELISTED
TEUCRIUM COMMODITY TR NATURAL GAS FD
NAGS
$188K ﹤0.01%
+14,321
New +$196K
ANAC
2227
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$188K ﹤0.01%
+10,611
New +$171K
SCU
2228
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$187K ﹤0.01%
+1,352
New +$174K
ANR
2229
DELISTED
Alpha Natural Resources Inc
ANR
$187K ﹤0.01%
50,427
-143,115
-74% -$576K
ATHX
2230
DELISTED
Athersys, Inc. Common Stock
ATHX
$186K ﹤0.01%
4,151
-2,533
-38% -$125K
ELP
2231
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$185K ﹤0.01%
30,163
-166,607
-85% -$985K
SVM
2232
Silvercorp Metals
SVM
$2.02B
$185K ﹤0.01%
+87,044
New +$167K
PHLT
2233
DELISTED
Performant Healthcare Inc
PHLT
$185K ﹤0.01%
+18,270
New +$167K
ITCI
2234
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$185K ﹤0.01%
+11,000
New +$182K
KRG icon
2235
Kite Realty
KRG
$5.86B
$184K ﹤0.01%
+7,473
New +$183K
RBBN icon
2236
Ribbon Communications
RBBN
$386M
$184K ﹤0.01%
10,267
-4,964
-33% -$84K
LBMH
2237
DELISTED
LIBERATOR MED HLDGS INC (NY)
LBMH
$182K ﹤0.01%
48,369
-2,064
-4% -$8.02K
AMED
2238
DELISTED
Amedisys
AMED
$181K ﹤0.01%
+10,817
New +$153K
CLS icon
2239
Celestica
CLS
$37.8B
$181K ﹤0.01%
14,384
-5,151
-26% -$59.3K
VCEL icon
2240
Vericel Corp
VCEL
$2.38B
$181K ﹤0.01%
44,245
+14,305
+48% +$59.2K
FRN
2241
DELISTED
Invesco Frontier Markets ETF
FRN
$181K ﹤0.01%
+10,546
New +$177K
HDY
2242
DELISTED
HYPERDYNAMICS CORP (NEW)
HDY
$177K ﹤0.01%
54,370
+37,052
+214% +$91.9K
RNA
2243
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
$176K ﹤0.01%
13,980
-2,650
-16% -$21.5K
RALY
2244
DELISTED
RALLY SOFTWARE DEV CORP
RALY
$175K ﹤0.01%
+16,095
New +$200K
DX
2245
Dynex Capital
DX
$3.17B
$174K ﹤0.01%
+6,571
New +$169K
FCF icon
2246
First Commonwealth Financial
FCF
$2.22B
$174K ﹤0.01%
+18,921
New +$166K
RFMD
2247
DELISTED
RF MICRO DEVICES INC
RFMD
$173K ﹤0.01%
18,005
-11,283
-39% -$100K
BRCD
2248
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$172K ﹤0.01%
18,711
-35,489
-65% -$327K
ARCW
2249
DELISTED
ARC Group Worldwide, Inc
ARCW
$172K ﹤0.01%
+11,303
New +$169K
ASEA icon
2250
Global X FTSE Southeast Asia ETF
ASEA
$98.6M
$168K ﹤0.01%
10,019
-62,855
-86% -$1.04M

Similar funds

Jane Street's Q2 2014 Portfolio in Review

As of Q2 2014, Jane Street held 3,648 positions worth $7.86B, down 13% from $9.04B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Jane Street withdrew a net $1.51B in Q2 2014, closing 1,159 positions and reducing 769 holdings. Its most notable exit was State Street SPDR S&P MIDCAP 400 ETF Trust, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Energy at 4.3% of assets, up from 3.2% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Jane Street opened a new position in Diageo worth $54.7M.

  • Jane Street's largest Q2 2014 buy was Diageo: 430,064 shares worth $54.7M.
  • Jane Street added most to AstraZeneca in Q2 2014, an estimated $132M increase.
  • Jane Street's biggest Q2 2014 reduction was WisdomTree Japan Hedged Equity Fund, cutting an estimated $157M.
  • Jane Street fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q2 2014, selling an estimated $152M.
  • Jane Street's ten largest holdings make up 19% of its $7.86B portfolio in Q2 2014.
  • Jane Street opened 1,015 new positions and closed 1,159 in Q2 2014.
  • Jane Street's portfolio value fell 13% quarter-over-quarter to $7.86B.

Based on Jane Street's 13F filing for Q2 2014, filed 14 Aug 2014.